Fenofibrate
Product Images NDC 70934-223

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 70934-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 223 30 Rev A 01 19)

Label (70934 223 30 Rev A 01 19)
FENOFIBRATE Tablets, 160 mg, in a package of 30 tablets by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label shows the NDC 70934-223-30 and storage instructions to keep between 20°-25°C. It is labeled for prescription use only with a note to see the package insert for dosage information.*
FDA Label Image

Fenofibrate-tablet-1 (Fenofibrate Tablets 54 mg And 160 mg 0115 1)

Fenofibrate-tablet-1 (Fenofibrate Tablets 54 mg And 160 mg 0115 1)
Chemical structure of fenofibrate showing its molecular arrangement with a chlorine-substituted benzene ring, ester linkage, and associated functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.